Skip to content

Office-based buprenorphine treatment; Board of Medicine to amend regulations.

It became law on Apr 6, 2026.

VA HB 712 · House Bill · 2026

Stage
Became law
Started in
House
Sponsor
Otto Wachsmann
Latest action
Apr 6, 2026

What it does

Board of Medicine; office-based buprenorphine treatment; counseling. Directs the Board of Medicine to amend its regulations regarding office-based buprenorphine treatment to require providers to offer counseling or referral to counseling to each patient as clinically necessary and mutually agreed-upon. The bill specifies that a patient's refusal of counseling does not preclude the patient from receiving office-based buprenorphine treatment for opioid use disorder. This bill is a recommendation of the Joint Commission on Health Care and is identical to SB 641.

Read the full text

Where it stands

This bill passed and is now law.

  1. Introduced (Done)

  2. Committee (Done)

  3. Floor (Done)

  4. Law (Done)

    Apr 6, 2026

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

It is law in Virginia. What happens now is up to the agency that carries it out, the courts, and the place itself.

Work with this bill

Office-based buprenorphine treatment; Board of Medicine to amend regulations. | 52